Engineered Hybrid Lantibiotic that Selectively Combats Infections Caused by Staphylococcus aureus
- 29 October 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 10 (11) , 3891-3901
Abstract
The rapid emergence of antibiotic-resistant strains of Staphylococcus aureus presents a substantial challenge to global public health, underscoring the urgent need for novel antibiotics with diverse mechanisms of action. In this study, we conducted mutagenesis on the C-terminal region of the lantibiotic ripcin C to enhance its antimicrobial efficacy against S. aureus. The resulting optimized variant, ripcin CP23A, demonstrated potent and selective antimicrobial activity, with a minimal inhibitory concentration of 2-4 mg/L against S. aureus. Beyond its strong antimicrobial properties, ripcin CP23A exhibited significant antibiofilm activity against methicillin-resistant S. aureus (MRSA). Mechanistic studies revealed that, in addition to targeting lipid II, ripcin CP23A disrupts bacterial membranes, a capability absent in ripcin C, which may contribute to its superior antimicrobial and antibiofilm effects. Moreover, ripcin CP23A displayed favorable biosafety and plasma stability profiles. Notably, in a mouse model of MRSA-induced mastitis, ripcin CP23A effectively reduced bacterial load, alleviated inflammation, and preserved the normal histomorphology of mammary glands. This study introduces ripcin CP23A as a promising antibiotic candidate for the treatment of MRSA-related infections.Keywords
Funding Information
- 1000 Talents Sichuan Program (1923, 2287)
- Chengdu Science and Technology Bureau (2024-YF05-02140-SN)
- Agriculture Research System of China (SCCXTD-2020-18)
- National Natural Science Foundation of China (32102689)
- Science and Technology Department of Sichuan Province (2022YFH0057, 2022YFH0062, 2022ZYD0068, 2024NSFSC2060)
This publication has 35 references indexed in Scilit:
- An antibiotic from an uncultured bacterium binds to an immutable targetCell, 2023
- Maslinic acid alleviates LPS-induced mice mastitis by inhibiting inflammatory response, maintaining the integrity of the blood-milk barrier and regulating intestinal floraInternational Immunopharmacology, 2023
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisThe Lancet, 2022
- Mimicry of a Non-ribosomally Produced Antimicrobial, Brevicidine, by Ribosomal Synthesis and Post-translational ModificationCell Chemical Biology, 2020
- Evolution of Lantibiotic Salivaricins: New Weapons to Fight Infectious DiseasesTrends in Microbiology, 2020
- A Deep Learning Approach to Antibiotic DiscoveryCell, 2020
- Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganismsHeliyon, 2019
- Altered expression of tight junction proteins in mammary epithelium after discontinued suckling in micePflügers Archiv - European Journal of Physiology, 2011
- Effect of Bioengineering Lacticin 3147 Lanthionine Bridges on Specific Activity and Resistance to Heat and ProteasesChemistry & Biology, 2010
- Expression of Claudin-1, -2, -3, -4, -5 and -7 Proteins in Benign and Malignant Canine Mammary Gland Epithelial TumoursJournal of Comparative Pathology, 2008